WELCOMING ADDRESS

Kaichi Kida (Symposium Organizer)

Ehime University School of Medicine, Ehime 791-0295, Japan

 

   Diabetes mellitus in children and adolescents is becoming one of the major targets of scientific interests and also one of major subjects of public concerns. The mechanisms for the development of type 1 diabetes and type 2 diabetes mellitus are gradually being unmasked by the recent progress in the molecular biology and gene biology and prediction/prevention of the two types of diabetes mellitus based on these knowledge is a big scientific challenge in this century. In the meantime, a well-organized care by a multidisciplinary team of health professionals is a key for achievement of a good QOL of children and adolescents with either type 1 or type 2 diabetes. Stepping into the reality of the world, even a minimum care for children and adolescents with diabetes to survive or avoid miserable complications of blindness or renal failure is not provided in many parts of the world.

   International Society for Pediatric and Adolescent Diabetes (ISPAD) is an international academic organization dealing with diabetes in children and adolescents which was founded in 1974 and has over 600 members in 70 countries. International Diabetes Federation (IDF) is a world-wide non- governmental organization founded in 1950 for well-being of patients with diabetes and their families which includes not only health professionals but lay people. The IDF Consultative Section on Childhood and Adolescent Diabetes has been working hard to assess the needs of children and adolescents with diabetes in the world and to take action to meet them. The activities of both organizations are directed to “Science of Diabetes”, “ Education of Diabetes” and ”Advocacy of Patients with Diabetes” in common. This time, ISPAD and IDF accordingly work together to organize a symposium here to deliver the latest knowledge and technology for cares of children and adolescents with diabetes and to insist on advocacy of them. I hope this symposium will be the first milestone for better cares of children and adolescents with diabetes in the 21st Century. 

 

 
2A-SS2-01